IS THE OCCURRENCE OF GESTATIONAL DIABETES MELLITUS IN PREGNANCIES HIGHER FOLLOWING IN VITRO FERTILIZATION TREATMENT? WHY? A RETROSPECTIVE COHORT STUDY (Retracted article. See vol. 7, pg. 553, 2023)
JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, cilt.7, sa.1, ss.94-102, 2023 (ESCI, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 7 Sayı: 1
- Basım Tarihi: 2023
- Doi Numarası: 10.30621/jbachs.1084860
- Dergi Adı: JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.94-102
- Anahtar Kelimeler: Gestational diabetes mellitus, in vitro fertilization, risk factors
- Dokuz Eylül Üniversitesi Adresli: Evet
Özet
Purpose: This study aim to determine the occurrence of gestational diabetes mellitus (GDM) in pregnancies after IVF treatment and to evaluate the factors that reduce this risk.Material and Methods: This retrospective cohort study was conducted using the medical records of pregnant women who conceived following IVF at the in-vitro fertilization center between 2002-2019. The data were obtained from medical records and phone interviews. Univariate and multivariate logistic regression analyses were performed.Results: The incidence of GDM was found to be 16.7%. The regression model indicated that the risk of GDM was 4.57 times higher in the age group 36-40 at conception during the IVF cycle than the age group 31-35 (95% CI = 1.18-17.73, p = .028). Furthermore, women who conceived after the second IVF trial had a risk of GDM 3.464 times higher than those that conceived after their first IVF trial (95% CI = 1.07-11.23, p= .038). Conclusion: As age and number of IVF trials increase in infertile women, the risk of GDM increases after IVF treatment.